Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 7, Issue 2, Pages 167-180
Publisher
Informa UK Limited
Online
2014-02-03
DOI
10.1586/17512433.2014.884458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells
- (2013) Sven Schnichels et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema
- (2013) Claus Zehetner et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Inhibition of Corneal Neovascularization by Subconjunctival and Topical Bevacizumab and Sunitinib in a Rabbit Model
- (2013) Byung-Yi Ko et al. CORNEA
- VEGF but not PlGF disturbs the barrier of retinal endothelial cells
- (2013) Heidrun L. Deissler et al. EXPERIMENTAL EYE RESEARCH
- Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells
- (2013) Heidrun L. Deissler et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Comparison of the Effect of Unilateral Intravitreal Bevacizumab and Ranibizumab Injection on Diabetic Macular Edema of the Fellow Eye
- (2013) Berker Bakbak et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
- (2013) Jeeyun Ahn et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Breaking the Aggregation of the Monoclonal Antibody Bevacizumab (Avastin®) by Dexamethasone Phosphate: Insights from Molecular Modelling and Asymmetrical Flow Field-Flow Fractionation
- (2013) Marieke Veurink et al. PHARMACEUTICAL RESEARCH
- ANATOMIC AND PHARMACOKINETIC PROPERTIES OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB AFTER VITRECTOMY AND LENSECTOMY
- (2013) John B. Christoforidis et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- EFFECTS OF INTRAVITREAL INJECTION OF BEVACIZUMAB ON INFLAMMATORY CYTOKINES IN THE VITREOUS WITH PROLIFERATIVE DIABETIC RETINOPATHY
- (2013) Yukihiko Suzuki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab
- (2012) Christoph Ehlken et al. ARCHIVES OF OPHTHALMOLOGY
- Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences
- (2012) Heidrun L Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab
- (2012) MA Fusco et al. Clinics
- Retinal Function and Morphology in Rabbit After Intravitreal Injection of VEGF Inhibitors
- (2012) Anna Cardiakidis Myers et al. CURRENT EYE RESEARCH
- Intravitreal bevacizumab increases intraocular interleukin-6 levels at 1day after injection in patients with proliferative diabetic retinopathy
- (2012) Sohee Jeon et al. CYTOKINE
- In Vitro Coagulation Effects of Ophthalmic Doses of Bevacizumab
- (2012) Emily Li et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- THE EFFECTS OF AFLIBERCEPT ON THE VIABILITY AND METABOLISM OF OCULAR CELLS IN VITRO
- (2012) David A. Ammar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion
- (2011) Michael J Koss et al. ACTA OPHTHALMOLOGICA
- Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab
- (2011) Ângela M. Carneiro et al. ACTA OPHTHALMOLOGICA
- Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-Control Study
- (2011) Roberto Dell'Omo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
- (2011) Tatsuhiko Sato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Prevention of Experimental Choroidal Neovascularization and Resolution of Active Lesions by VEGF Trap in Nonhuman Primates
- (2011) T. Michael Nork ARCHIVES OF OPHTHALMOLOGY
- Comparing protein VEGF inhibitors: In vitro biological studies
- (2011) Lanlan Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells
- (2011) H. L. Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparison of choroidal and retinal endothelial cells: Characteristics and response to VEGF isoforms and anti-VEGF treatments
- (2011) Elizabeth A. Stewart et al. EXPERIMENTAL EYE RESEARCH
- Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
- (2011) C H Meyer et al. EYE
- Effects of intravitreal bevacizumab (Avastin) on the porcine retina
- (2011) Ianors Iandiev et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant Biomarker
- (2011) Tatjana M. H. Niers et al. PLoS One
- SAFETY OF INTRAVITREAL BEVACIZUMAB IN THE DEVELOPING RABBIT RETINA
- (2011) Shiri Zayit-Soudry et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS
- (2011) Carsten H Meyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of Reflux of Drug During Intravitreal Anti-VEGF Therapies on Foveal Thickness
- (2011) Muhammad Usman Saeed et al. Seminars in Ophthalmology
- Reflux of Drug During Intra-vitreal Anti-VEGF Therapies
- (2011) Muhammad Usman Saeed et al. Seminars in Ophthalmology
- Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage
- (2010) Sebastian Thaler et al. ACTA OPHTHALMOLOGICA
- Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans
- (2010) Carsten H. Meyer et al. ACTA OPHTHALMOLOGICA
- The in vitro response of human retinal endothelial cells to cytokines and other chemically active agents is altered by coculture with vitreous-derived hyalocytes
- (2010) Naoki Tojo et al. ACTA OPHTHALMOLOGICA
- Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
- (2010) Irene A. Barbazetto et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreous Bevacizumab Injection
- (2010) Rafael T. Cortez ARCHIVES OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
- (2010) K. Matsuyama et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
- (2010) T. J. Good et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Testing toxicity of multiple intravitreal injections of bevacizumab in rabbit eyes
- (2010) Weiqi Xu et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats
- (2010) Jin Ma et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- The Effect of Methotrexate on Corneal Neovascularization in Rabbits
- (2010) Yong-Soo Byun et al. CORNEA
- Influence of Non-Toxic Doses of Bevacizumab and Ranibizumab on Endothelial Functions and Inhibition of Angiogenesis
- (2010) Aya Barzelay et al. CURRENT EYE RESEARCH
- Effects of Pegaptanib Sodium on Retinal Function in Isolated Perfused Vertebrate Retina
- (2010) Matthias Lüke et al. CURRENT EYE RESEARCH
- Burden of illness of diabetic macular edema: literature review
- (2010) Er Chen et al. CURRENT MEDICAL RESEARCH AND OPINION
- Intravitreal Injection of Bevacizumab Induces Inflammatory Alterations in a Uveitis Experimental Model
- (2010) Siv Johnsen-Soriano et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle
- (2010) Katrin Lorenz et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intracellular bevacizumab reduces phagocytotic uptake in RPE cells
- (2010) Alexa Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- VEGF Antagonists Decrease Barrier Function of Retinal Pigment Epithelium In Vitro: Possible Participation of Intracellular Glutathione
- (2010) Y. Miura et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Lack of Therapeutic Effect of Ranibizumab in Fellow Eyes After Intravitreal Administration
- (2010) Maria-Andreea Gamulescu et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Aqueous Humor Concentration of Bevacizumab After Subconjunctival Injection in Rabbit
- (2010) Moon Jung Kim et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- ANGIOGENIC AND INFLAMMATORY MARKERS IN THE INTRAOCULAR FLUID OF EYES WITH DIABETIC MACULAR EDEMA AND INFLUENCE OF THERAPY WITH BEVACIZUMAB
- (2010) Marion Funk et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF PEGAPTANIB OR RANIBIZUMAB IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
- (2010) Osamu Sawada et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- HIGH-MOLECULAR-WEIGHT AGGREGATES IN REPACKAGED BEVACIZUMAB
- (2010) Malik Y Kahook et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- In vitroevaluation of bevacizumab toxicity on a retinal ganglion cell line
- (2009) Rajesh K. Sharma et al. ACTA OPHTHALMOLOGICA
- Effect of Intravitreal Bevacizumab (Avastin) on the Growing Rabbit Eye
- (2009) Ruth Axer-Siegel et al. CURRENT EYE RESEARCH
- Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits
- (2009) Saloomeh Saati et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection
- (2009) Yukiko Shimomura et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab
- (2009) Kayako Matsuyama et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study
- (2009) Raquel Costa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of Intracameral Bevacizumab Injection on Corneal Endothelial Cells: An In Vivo Evaluation
- (2009) Mohamed H. Hosny et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Evaluation of Differential Toxicity of Varying Doses of Bevacizumab on Retinal Ganglion Cells, Retinal Pigment Epithelial Cells, and Vascular Endothelial Growth Factor–Enriched Choroidal Endothelial Cells
- (2009) Vikram S. Brar et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor
- (2009) Katsuaki Miki et al. OPHTHALMOLOGY
- Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab
- (2009) Marion Funk et al. OPHTHALMOLOGY
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
- (2008) Mark H. Criswell ARCHIVES OF OPHTHALMOLOGY
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells
- (2008) H Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells
- (2008) Ângela Carneiro et al. EXPERIMENTAL EYE RESEARCH
- Reduction of pegaptanib loss during intravitreal delivery using an oblique injection technique
- (2008) L Lopez-Guajardo et al. EYE
- Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
- (2008) Osamu Sawada et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?
- (2008) Fang Lu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization
- (2008) Qi Zhu et al. OPHTHALMOLOGY
- Effect of Intravitreal Bevacizumab Injection on Aqueous Humor Cytokine Levels in Clinically Significant Macular Edema
- (2008) Mi In Roh et al. OPHTHALMOLOGY
- CHANGES IN AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AND PIGMENT EPITHELIAL-DERIVED FACTOR LEVELS FOLLOWING INTRAVITREAL BEVACIZUMAB INJECTIONS FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION OR PATHOLOGIC MYOPIA
- (2008) WAI-MAN CHAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now